Latest On Krystal Biotech Inc ALL CNBCINVESTING CLUBPRO SummaryNewsProfileEarningsPeersFinancialsOptionsOwnership KEY STATS Open171.20 Day High172.71 Day Low165.08 Prev Close169.12 52 Week High219.34 52 Week High Date07/26/24 52 Week Low141.72 52 Week Low Date01/14/25 Market Cap4.857B Shares Out...
692,771 52 week range 133.22-219.34 Latest On Krystal Biotech Inc KEY STATS Open140.64 Day High140.64 Day Low133.22 Prev Close139.47 52 Week High219.34 52 Week High Date07/26/24 52 Week Low133.22 52 Week Low Date05/07/25 Market Cap3.953B ...
KRYS Krystal Biotech Watchlist 166.160 +0.470+0.28% Close May 2 16:00 ET 166.160 0.0000.00% Post 16:05 ET 4.80BMarket Cap55.39P/E (TTM) 169.310High165.530Low228.17KVolume168.180Open165.690Pre Close38.07MTurnover1.00%Turnover Ratio55.39P/E (Static)28.90MShares219.34052wk High5.07P/B3.81BFloat...
Check Krystal Biotech Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. KRYS Stock Performance Previous close 136.8 Day range 132.475 - 141.37 Year range 132 - 219 Market cap 4,801,758,000 Primary exchange NASDAQ ...
Krystal Biotech ((KRYS)) has issued an update. Krystal Biotech announced positive initial clinical results from its KYANITE-1 study on inhaled KB707 for lung tumors, particularly showing monotherapy efficacy in advanced non-small cell lung cancer (NSCLC) patients. The study demonstrated a 27% obje...
Earnings estimates and surprises for Krystal Biotech Inc (KRYS) are an important tool used to evaluate the company's overall strength and value of the stock.
Biotech Investing Tech Stocks Quantitative Investing Learn Investing Resources Investing Education Investing Strategies Retirement Investing Stock Market Sectors Stock Market Holidays & Hours After Hours Trading Portfolio Management Cryptocurrency Dividend Investing Portfolio Strategy Fixed Income ...
Why Krystal Biotech's Shares Rose More Than 77% This Week Jim Halley | Dec 2, 2021 The company had a positive phase 3 trial for its therapy to fight a rare genetic skin disease. View More KRYS Articles Valuation Related Stocks NASDAQ: TXG 10x Genomics Market Cap $1B Current Pric...
Krystal Biotech Inc. (KRYS) $183.921.17(0.64%) Bid: 176.54 x 100Ask: 194.08 x 100 March 28, 2025 4:00 PMEDTVolume: 224,610 After Hours: $183.920.00(0.00%)March 28, 2025 4:00 PMEDTVolume: 4,100 USDNasdaq Global SelectDelayed PriceMarket Closed Earnings High Target Price 245.00 Mean...
Latest On Krystal Biotech Inc ALL CNBCINVESTING CLUBPROSummaryNewsProfileEarningsPeersFinancialsOptionsOwnership KEY STATS Open136.32 Day High141.37 Day Low132.48 Prev Close136.80 52 Week High219.34 52 Week High Date07/26/24 52 Week Low132.48 52 Week Low Date05/08/25 Market Cap3.964B Shares Out...